Breaking News: Ebola

Filters close
9-Jan-2018 5:05 PM EST
TSRI Scientists Discover Workings of First Promising Marburg Virus Treatment
Scripps Research Institute

Scientists at The Scripps Research Institute have discovered the workings of the first promising treatment for Marburg virus, a pathogen with the same pandemic potential as Ebola virus.

   
Released: 14-Dec-2017 12:05 AM EST
40 Years After First Ebola Outbreak, Survivors Show Signs They Can Stave Off New Infection
University of California, Los Angeles (UCLA), Health Sciences

Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks

   
Released: 16-Nov-2017 4:05 PM EST
Unlocking the Secrets of Ebola
Pacific Northwest National Laboratory

Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease. The results come from one of the most in-depth studies ever of blood samples from patients with Ebola.

   
14-Nov-2017 4:30 PM EST
In the Heart of Devastating Outbreak, Research Team Unlocks Secrets of Ebola
University of Wisconsin–Madison

In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin–Madison has identified signatures of Ebola virus disease that may aid in future treatment efforts.

8-Nov-2017 8:55 AM EST
Closing the Rural Health Gap: Media Update from RWJF and Partners on Rural Health Disparities
Newswise

Rural counties continue to rank lowest among counties across the U.S., in terms of health outcomes. A group of national organizations including the Robert Wood Johnson Foundation and the National 4-H Council are leading the way to close the rural health gap.

       
Released: 29-Sep-2017 4:00 PM EDT
Researchers Identify Protein That Could Reduce Death, Improve Symptoms In Influenza and Other Infectious Diseases
University of Maryland School of Medicine

A new study by researchers has identified an innovative strategy for treating influenza, and perhaps other infectious diseases as well. Scientists showed that a small protein called retrocyclin-101 (RC-101) could potentially improve the symptoms and mortality associated with the flu and possibly other types of infectious illness as well.

Released: 27-Sep-2017 1:05 PM EDT
Novel Vaccine for Ebola and other Hemorrhagic Fever Viruses
Thomas Jefferson University

A collaboration among research institutions, private industry, and the US Government will develop a tetravalent vaccine to protect against four viruses that can be fatal

Released: 21-Sep-2017 3:40 PM EDT
Trusted Messages Key to Counter Community Concerns During Disease Outbreak
University of Louisville

Utilizing messages focused on images created by local artists and written information communicated through local dialects proved essential to counter misperceptions during the Ebola epidemic in Sierra Leone, according to a study conducted in part by Muriel J. Harris, Ph.D., associate professor, University of Louisville School of Public Health and Information Sciences, Department of Health Promotion and Behavior Sciences.

Released: 24-Aug-2017 2:05 PM EDT
DNA Detectives Crack the Case on Biothreat Look-Alikes
Los Alamos National Laboratory

Biological “detectives” are tracking down biothreats such as the bacteria that causes tularemia (“rabbit fever”), but they constantly face the challenge of avoiding false positives.

   
Released: 21-Aug-2017 1:05 PM EDT
Johns Hopkins Materials Scientists Probe a Protein’s Role in Speeding Ebola’s Spread
 Johns Hopkins University

Scientists have pinpointed how a tiny protein seems to make the deadly Ebola virus particularly contagious.

   
Released: 11-Aug-2017 11:05 AM EDT
Einstein Researchers Awarded Three NIH Grants Totaling $12Million to Fight Virulent Viruses
Albert Einstein College of Medicine

The NIH has awarded Einstein researchers three grants totaling more than $12 million to protect against three deadly viruses—Ebola, Marburg and hantavirus. Research collaborations between Kartik Chandran, Ph.D., professor of microbiology & immunology and the Harold and Muriel Block Faculty Scholar in Virology, and Jonathan Lai, Ph.D., associate professor of biochemistry, have led to novel approaches for developing vaccines and treatments.

Released: 2-Aug-2017 3:05 PM EDT
Ebola Detected in Semen of Survivors Two Years After Infection
University of North Carolina Health Care System

Researchers at the University of North Carolina at Chapel Hill have found Ebola RNA in the semen of survivors two years after infection. They are calling on the World Health Organization to update its guidelines on sexual transmission.

Released: 16-Jul-2017 10:00 AM EDT
Ebola Lingers in Survivors’ Eyes
Association for Research in Vision and Ophthalmology (ARVO)

Three years after an Ebola epidemic swept across West Africa, researchers have found a clue to how the virus may live on in the eyes of survivors suffering from uveitis – one of the more serious and common complications of the disease.

Released: 11-Jul-2017 11:05 AM EDT
Tulane University Awarded $12 Million to Create Lassa Fever Vaccine and Treatment
Tulane University

The National Institutes of Health has awarded Tulane University more than $12 million to test a promising drug treatment against Lassa fever and develop a vaccine against the deadly disease endemic in parts of West Africa.

Released: 14-Jun-2017 6:05 PM EDT
Influenza Virus Can Overcome Potentially Crippling Mutations
Scripps Research Institute

Scientists at The Scripps Research Institute (TSRI) have shown that for the virus that causes the flu, two wrongs can sometimes make a right.

   
Released: 13-Jun-2017 1:05 PM EDT
Argonne X-Rays Used to Help Identify a Key Lassa Virus Structure
Argonne National Laboratory

Research done at Argonne National Laboratory’s Advanced Photon Source was vital to the process of identifying the structure, which provides a guide for designing a Lassa virus vaccine. Lassa virus is endemic to Africa and kills thousands of people a year; it is particularly deadly for pregnant women.

Released: 12-Jun-2017 9:05 PM EDT
Pregnancy Problems Not Necessarily Tied to Zika Viral Load or Dengue Fever
University of California, Los Angeles (UCLA), Health Sciences

Zika viral load and the degree of Zika symptoms during pregnancy are not necessarily associated with problems during pregnancy or fetal abnormalities at birth. The presence of antibodies to previously acquired dengue fever also is not necessarily linked to abnormalities during pregnancy or at birth.

Released: 8-Jun-2017 11:00 AM EDT
Tackling infectious disease – one protein at a time
Pacific Northwest National Laboratory

A team of scientists in the Pacific Northwest has solved the 3-D structure of 1,000 proteins from more than 70 organisms that cause infectious disease in people. The proteins come from microbes that cause several serious diseases, including tuberculosis, Listeria, Giardia, Ebola, anthrax, C. diff., Legionella, Lyme, chlamydia and the flu.

Released: 6-Jun-2017 5:05 PM EDT
Tulane Researchers Help Find Possible Explanation for Unparalleled Spread of Ebola Virus
Tulane University

The world may be closer to knowing why Ebola spreads so easily thanks to a team of researchers from Tulane University and other leading institutions who discovered a new biological activity in a small protein from the deadly virus.

31-May-2017 5:00 PM EDT
Perseverance Pays Off in Fight Against Deadly Lassa Virus
Scripps Research Institute

This story starts with a young graduate student in San Diego and leads all the way to Sierra Leone, to a unique hospital where Lassa fever victims arrive by the thousands every year.

Released: 25-May-2017 3:05 PM EDT
Congo Ebola Outbreak: Health Care Providers Should Review Response Plans
University of Michigan

With an Ebola outbreak underway in the Democratic Republic of Congo, experts say health care providers should review their Ebola response plans now to avoid repeating past mistakes.

Released: 18-May-2017 11:05 AM EDT
Department of Energy Secretary Recognizes Argonne Scientists’ Work to Fight Ebola, Cancer
Argonne National Laboratory

Two groups of researchers at Argonne earned special awards from the office of the U.S. Secretary of Energy for addressing the global health challenges of Ebola and cancer.

   
12-May-2017 8:00 AM EDT
Ebola: Lives to Be Saved with New Management Approach
University of Warwick

Ebola outbreaks are set to be managed quickly and efficiently – saving lives – with a new approach developed by an international team of researchers, including the University of Warwick, which helps to streamline outbreak decision-making.

   
Released: 25-Apr-2017 11:05 AM EDT
Using 3-D Weapons of Science to Fight Infectious Diseases
UT Southwestern Medical Center

UT Southwestern Medical Center researchers collaborated with an international team of scientists to achieve a significant milestone in the effort to understand pathogens responsible for some of the world’s most deadly infectious diseases.

Released: 20-Apr-2017 10:45 AM EDT
Sandia Honored for Fighting Ebola, Analyzing Emerging Biotechnologies
Sandia National Laboratories

Researchers at Sandia National Laboratories just received recognition from the Secretary of Energy for their work to mitigate the effects of the 2014 Ebola epidemic. Reducing the amount of time Liberians who suspected they had Ebola spent waiting in large, open waiting rooms called Ebola treatment units was critical to controlling the outbreak. Sandia modeled and analyzed the West Africa nation’s blood sample transport system from the treatment units to diagnostic labs and made recommendations to improve turnaround time.

Released: 18-Apr-2017 10:00 AM EDT
The "Geneva Signature" Measures the Safety and Efficiency of a Vaccine Against Ebola Virus Disease
Université de Genève (University of Geneva)

The 2014–2015 Ebola epidemic affected several countries in West Africa, leading to the death of more than 11'000 people. Although this epidemic of Ebolavirus disease is over, there is no knowing if, when or where another may strike. It is therefore more important than ever to find a reliable vaccine against this deadly disease. Research on vaccines, which was ongoing during the epidemic in West Africa, is now yielding promising results.

Released: 17-Apr-2017 10:05 AM EDT
Could Yellow Fever Rise Again?
Perelman School of Medicine at the University of Pennsylvania

Many people might not have heard of the Aedes aegypti mosquito until this past year, when the mosquito, and the disease it can carry – Zika – began to make headlines. But more than 220 years ago, this same breed of mosquito was spreading a different and deadly epidemic right here in Philadelphia and just like Zika, this epidemic is seeing a modern resurgence, with Brazil at its epicenter.

Released: 12-Apr-2017 1:30 PM EDT
A Big-Picture Look at the World’s Worst Ebola Epidemic
Fred Hutchinson Cancer Center

An international effort to analyze the entire database of Ebola virus genomes from the 2013-2016 West African epidemic reveals insights into factors that sped or slowed the rampage and calls for using real-time sequencing and data-sharing to contain future viral disease outbreaks.

Released: 11-Apr-2017 2:05 PM EDT
Texas Biomed Part of Research Efforts to Screen and Develop Ebola Virus Drug
Texas Biomedical Research Institute

Dr. Robert Davey, Scientist at Texas Biomedical Research Institute, is part of a team of researchers working to find new drugs that will stop Ebola virus from growing inside infected cells. Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $4.1 million federal grant for this project.

Released: 10-Apr-2017 2:05 PM EDT
New Model Maps Likelihood of Ebola Spillovers
University of Georgia

Ecologists at the University of Georgia have developed a model that maps the likelihood of Ebola virus “spillovers”—when the virus jumps from its long-term host to humans or animals such as great apes—across Africa on a month-by-month basis.

Released: 4-Apr-2017 5:05 PM EDT
Pre-Existing Immunity to Dengue and West Nile Viruses May Cause Increased Risk in Zika-Infected
Mount Sinai Health System

As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found. Their study, published in the journal Science, may help explain the severe manifestations of Zika virus infection observed in specific populations, including those in South America.

Released: 13-Mar-2017 10:00 AM EDT
Georgia State Researcher Gets $4.1 Million Federal Grant to Develop Drug to Combat Ebola Virus
Georgia State University

Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university’s Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus.

Released: 3-Feb-2017 7:00 AM EST
Ebola Grant Expanded From $12 Million to $24 Million
University of Nebraska Medical Center (UNMC)

Supplemental funding will allow three partner institutions to perform additional site visits, conduct more education and training courses, as well as build a special pathogens research network.

Released: 23-Dec-2016 10:05 AM EST
UF Plays Key Role in Trial for Successful Ebola Vaccine
University of Florida

An international group of researchers associated with the World Health Organization has published its final report on the Ebola vaccine trial in Guinea, finding that the vaccine is a safe and effective way to prevent Ebola infection.

Released: 23-Dec-2016 8:30 AM EST
Trial Results Confirm Ebola Vaccine Provides High Protection Against Disease
University of Maryland School of Medicine

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to a new study that included researchers from the University of Maryland School of Medicine.

Released: 10-Nov-2016 8:00 AM EST
Collaborations Pharmaceuticals, Inc. And Texas Biomed Announce NIH Award to Develop a Treatment for Ebola
Texas Biomedical Research Institute

The National Center for Advancing Translational Sciences (NCATS) recently awarded $596,533.00 to Collaborations Pharmaceuticals, Inc. (CPI) to initiate a partnership with Texas Biomedical Research Institute aimed at repurposing an antimalarial for use against the Ebola virus.

2-Nov-2016 3:25 PM EDT
New TSRI Study Suggests Ebola Can Adapt to Better Target Human Cells
Scripps Research Institute

A new study co-led by scientists at The Scripps Research Institute (TSRI) suggests that Ebola virus gained a genetic mutation during the 2013–16 epidemic that appears to have helped it better target human cells.

   
Released: 28-Sep-2016 2:05 PM EDT
Sociol-Ecological System Approach Leads to New Information in Study of Mosquito-Borne Viruses
SUNY Upstate Medical University

In an article published online Sept. 13 in UGEC Viewpoints , Upstate Medical University researcher Anna Stewart Ibarra, PhD, MPA, describes how a collaborative approach by researchers of varying disciplines is being used as a framework for studying the mosquito-borne viruses, zika, dengue and chikungunya.

6-Sep-2016 12:00 PM EDT
New ‘Trojan Horse’ Antibody Strategy Shows Promise Against All Ebola Viruses
Albert Einstein College of Medicine

In research published in Science, a team of scientists describe a new therapeutic strategy to target a hidden Achilles’ heel shared by all known types of Ebola virus. Two antibodies developed with this strategy blocked the invasion of human cells by all five ebolaviruses. The team included scientists from Albert Einstein College of Medicine, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Integrated Biotherapeutics, Vanderbilt University Medical Center, and The Scripps Research Institute.

Released: 8-Aug-2016 4:05 PM EDT
TSRI Scientists Pinpoint Ebola’s Weak Spots
Scripps Research Institute

Scientists at The Scripps Research Institute now have a high-resolution view of exactly how the experimental therapy ZMapp targets Ebola virus.

29-Jul-2016 4:05 PM EDT
Collateral Harm: The Impact of Ebola and Related Fears on Facility-Based Child Deliveries
Georgetown University Medical Center

The first known household survey examining the collateral harm to pregnancy services in areas affected by the West African Ebola epidemic suggests a significant slide backwards in child and maternal health. The study, conducted in Liberia, points to the deep disruptions caused by the Ebola epidemic — even in parts of the country with relatively limited transmission.

Released: 28-Jul-2016 8:05 AM EDT
As Hazard Warnings Increase, Experts Urge Better Decisions on Who and When to Warn
Society for Risk Analysis (SRA)

Effective warnings are a growing need as expanding global populations confront a wide range of hazards, such as a hurricane, wildfire, toxic chemical spill or any other environmental hazard threatens safety.

       
14-Jul-2016 9:00 AM EDT
Ecologists Identify Potential New Sources of Ebola and Other Filoviruses
University of Georgia

Researchers identify bat species most likely to carry filoviruses and map hotspots for disease surveillance and virus discovery efforts.

Released: 6-Jul-2016 2:05 PM EDT
Quick, Early Test for Ebola Could Prevent Epidemics
Princeton University

Researchers from Princeton University are joining with colleagues from U.S. government laboratories in an effort to dramatically improve the test for the Ebola virus. The goal is to offer a quick, accurate and inexpensive method to help contain future epidemics.

Released: 30-Jun-2016 2:05 PM EDT
U.S. Needs Greater Preparation for Next Severe Public Health Threats, Independent Panel Finds
University of California, Los Angeles (UCLA), Health Sciences

An Independent Panel formed to review the U.S. Department of Health and Human Service’s response to Ebola calls for increased coordination both within HHS and across all involved federal agencies and strengthened coordination and collaboration with state and local governments and their private-sector partners.

Released: 27-Jun-2016 11:05 AM EDT
Political Pitfalls in Handling Ebola May Carry Over to Zika
University of Michigan

If the United States responds to Zika the way it did to Ebola—and early indications are that in many ways it is—the country can expect missteps brought about by a lack of health care coordination and a lot of political finger pointing, according to an analysis by the University of Michigan.

   
Released: 22-Jun-2016 11:05 AM EDT
Johns Hopkins Students Design Ebola Protection Suit Improvements
 Johns Hopkins University

Johns Hopkins University engineering students working to develop a better suit to protect health care workers in Ebola outbreaks have developed prototypes for a more comfortable hood and face mask that make breathing easier, and for a battery-powered system that curbs humidity in the suit.

Released: 16-Jun-2016 12:05 PM EDT
Sandia Researchers Discover Mechanism for Rift Valley Fever Virus Infection
Sandia National Laboratories

Rift Valley fever virus and other bunyaviruses may soon be added to the list of viruses denied access to a human host. Sandia National Laboratories researchers have discovered a mechanism by which RVFV hijacks the host machinery to cause infection

Released: 15-Jun-2016 4:05 PM EDT
Simulations Describe HIV’s ‘Diabolical Delivery Device’
University of Chicago

University of Chicago scientists and their colleagues have developed an innovative computer model of HIV that gives real insight into how a virus “matures” and becomes infective.


Showing results 101–150 of 312


close
1.34653